文献速递前列腺癌

基于多组学胶原模型预测前列腺癌根治术后生化复发

Prediction of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy by Collagen Models Using Multiomic Profiles.
PubMed 文献 · Eur Urol Oncol · 2025-05-01

本研究分析了55个胶原相关特征在转录组数据集(n=1393)中的预后价值,并在蛋白质组(n=69)和尿液肽组(n=73)中验证。多变量模型整合胶原转录本提高了预后准确性,优于临床变量;尿液胶原模型显示强预后潜力,但受样本量小限制。

要点

  • 胶原相关转录本模型可提升RP术后BCR预测准确性
  • 尿液胶原模型C-index为0.73,具无创预后潜力
  • 组织胶原模型对总生存也有显著预后价值

核心结论

  • 组织和尿液中的胶原相关分子特征可作为预测RP术后BCR的稳健预后生物标志物。

研究设计与样本

  • 回顾性分析转录组数据集(n=1393)中55个胶原相关特征,并在蛋白质组(n=69)和尿液肽组(n=73)中验证。
  • 使用Cox比例风险模型评估独立预后意义,并与临床指标基准比较。

主要发现

  • 55个胶原相关转录本中11个与BCR显著相关(C-index:0.55-0.72,p < 0.002)。
  • 多变量模型整合这些转录本后预后准确性超越临床变量(C-index:0.66-0.89,p < 0.002)。
  • 蛋白质组验证确认5个关键胶原蛋白。
  • 尿液胶原模型C-index为0.73(95% CI:0.62-0.85),显示强预后潜力。
  • 组织胶原模型预测总生存C-index为0.59-0.70(p < 0.01)。

关键数值与推荐

  • 胶原转录本单独预测BCR的C-index范围为0.55-0.72(p < 0.002)。
  • 整合胶原转录本的多变量模型C-index范围为0.66-0.89(p < 0.002)。
  • 尿液胶原模型C-index为0.73(95% CI:0.62-0.85)。
  • 组织胶原模型预测总生存C-index为0.59-0.70(p < 0.01)。

临床怎么用

  • 胶原模型可辅助RP术后BCR风险分层,尿液检测有望成为无创工具。
  • 需进一步大样本验证后方可临床常规使用。

局限性

  • 尿液验证队列样本量小(n=73)。
  • 蛋白质组验证样本量有限(n=69)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVE: The interplay between prostate cancer and the tumor microenvironment is well documented and of primary importance in disease evolution. Herein, we investigated the prognostic value of tissue and urinary collagen-related molecular signatures in predicting biochemical recurrence (BCR) after radical prostatectomy (RP). METHODS: A comprehensive analysis of 55 collagen-related features was conducted using transcriptomic datasets (n = 1393), with further validation at the proteomic level (n = 69). Additionally, a distinct cohort (n = 73) underwent a urine-based peptidomic analysis, culminating in the validation of a urine-derived prognostic model. Independent prognostic significance was assessed using Cox proportional hazards modeling, while the model's predictive performance was benchmarked against established clinical metrics. KEY FINDINGS AND LIMITATIONS: An expression analysis of 55 collagen-related transcripts identified 11 transcripts significantly associated with BCR (C-index: 0.55-0.72, p < 0.002). Multivariable models incorporating these transcripts enhanced prognostic accuracy, surpassing clinical variables (C-index: 0.66-0.89, p < 0.002). Proteomic validation confirmed five key collagen proteins, while a urine-based collagen model (C-index: 0.73, 95% confidence interval: 0.62-0.85) demonstrated a strong prognostic potential, although limited by small patient numbers. Additionally, tissue collagen-based models predicted overall survival with a significant prognostic value (C-index: 0.59-0.70, p < 0.01). CONCLUSIONS AND CLINICAL IMPLICATIONS: Collagen-based molecular signatures in both tissue and urine emerge as robust prognostic biomarkers for predicting BCR following RP.

来源:Eur Urol Oncol,查看原文。版权归原作者所有。

引用

  1. Frantzi M, Tymoszuk P, Salcher S, et al. Prediction of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy by Collagen Models Using Multiomic Profiles. Eur Urol Oncol. 2025. PMID: 40312179. doi:10.1016/j.euo.2025.03.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。